Additionally, in lung cancer, disruption of SIRT7-ARF signaling stabilizes ARF and thus attenuates cancer cell proliferation, providing a strategy to mitigate NSCLC progression (Kumari et al., 2024). Here, CDKN2A is linked to cancer.